Laninamivir
- Generic Name
- Laninamivir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H22N4O7
- CAS Number
- 203120-17-6
- Unique Ingredient Identifier
- B408IW3GL5
- Background
Laninamivir has been used in trials studying the treatment of Influenza.
- Indication
用于儿童和成人流感病毒感染的治疗和预防。
- Associated Conditions
- -
- Associated Therapies
- -
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
Phase 2
Recruiting
- Conditions
- InfluenzaInfluenza, Human
- Interventions
- First Posted Date
- 2022-12-13
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 3000
- Registration Number
- NCT05648448
- Locations
- 🇧🇷
Universidade Federal de Minas Gerais, Minas Gerais, Brazil
🇱🇦Laos-Oxford-Mahosot Wellcome Trust Research unit, Vientiane, Lao People's Democratic Republic
🇳🇵Sukraraj Tropical & Infectious Disease Hospital, Kathmandu, Nepal
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath